Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the Combined Symptom and Medication Score (CSMS) in Patients Suffering From Allergic Rhinoconjunctivitis Induced by Tree Pollen, Grass Pollen or House Dust Mites Who Are Treated Exclusively With Symptomatic Medication

NCT04071249 is registered in ClinicalTrials.gov with ClinNovis GmbH as lead sponsor.

NCT NCT04071249
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04071249 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the Combined Symptom and Medication Score (CSMS) in Patients Suffering From Allergic Rhinoconjunctivitis Induced by Tree Pollen, Grass Pollen or House Dust Mites Who Are Treated Exclusively With Symptomatic Medication
Lead sponsor
ClinNovis GmbH
Phase
Observational
Overall status
Completed
Start date
October 10, 2019
Completion date
August 25, 2020
Enrollment
55 (actual)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

rhinoconjunctivitis, allergic